Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunities.
| Autor: | Keyloun KR; Digital and Data Strategy, AbbVie, CA, USA., Abel J; Patient Centered Outcomes Research, AbbVie, CA, USA., Garcia JK; Patient Centered Outcomes Research, AbbVie, CA, USA., Papadopoulos EJ; Patient Centered Outcomes Research, AbbVie, CA, USA., Carson RT; Patient Centered Outcomes Research, AbbVie, CA, USA., Gwaltney C; Gwaltney Consulting, Westerly, RI, USA., Slagle AF; Aspen Consulting, LLC, Steamboat Springs, CO, USA., Byrom B; eCOA Science, Signant Health, Nottingham, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Jul; Vol. 24 (6), pp. 723-730. Date of Electronic Publication: 2024 Jun 11. |
| DOI: | 10.1080/14737167.2024.2362291 |
| Abstrakt: | Introduction: Sensor-based digital health technology (DHT) has emerged as a promising means to assess patient functioning within and outside clinical trials. Sensor-based functional outcomes (SBFOs) provide valuable insights that complement other measures of how a patient feels or functions to enhance understanding of the patient experience to inform medical product development. Areas Covered: This perspective paper provides recommendations for defining SBFOs, discusses the core evidence required to support SBFOs to inform decision-making, and considers future directions for the field. Expert Commentary: The clinical outcome assessment (COA) development process provides an important starting point for developing patient-centered SBFOs; however, given the infancy of the field, SBFO development may benefit from a hybrid approach to evidence generation by merging exploratory data analysis with patient engagement in measure development. Effective SBFO development requires combining unique expertise in patient engagement, measurement and regulatory science, and digital health and analytics. Challenges specific to SBFO development include identifying concepts of interest, ensuring measurement of meaningful aspects of health, and identifying thresholds for meaningful change. SBFOs are complementary to other COAs and, as part of an integrated evidence strategy, offer great promise in fostering a holistic understanding of patient experience and treatment benefits, particularly in real-world settings. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|